Subscribe to:
POZ magazine E-newsletters
POZ Personals Sign In / Join
Username:
Password:
Women's Hub News

                
          

Back to home » News & Views » News


December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007
April 2007
March 2007
February 2007

emailrssprint

November 20, 2007

HIV Med Market Boom

A new financial analysis of the HIV drug market highlights the potential reshuffling of market positions as the patents of AIDS drugs expire (money.cnn.com, 11/19).

It is estimated that the $8 billion HIV drug market will expand by approximately 50 percent by 2016, says analyst Mansi Shah of research company Datamonitor.

With two thirds of current HIV drug patents expiring in the next 10 years, more and more companies are expected to challenge top drugmakers. In addition, experts attribute the booming market to advanced HIV medications, which will keep those living with the virus—and the drug market—alive and well for years to come.

“HIV patients live much longer,” says Jason Zhang, an analyst for BMO Capital Markets. “They have the disease for life, and that’s why the market is growing.”

NEW! Scroll down to comment on this story.

emailrssprint

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team review all comments before they are posted. Please do not include either ":" or "@" in your comment.)

| Posting Rules

Previous Comments:

  comments 1 - 3 (of 3 total)    

Zachary, Denver, CO, 2007-11-28 15:36:46
Better that the market not be growing? Developing a cure for a disease by no means ensures the eradication of that disease. Someone somewhere will always need meds. A manufacturer who could produce a cure for HIV infection would stand to reap enormous profits.

Ryan, Queens, 2007-11-28 15:18:40
I think the drug companies are more focused on trying to maintain HIV/AIDS as to curing it. We all know for a fact that drug companies moto is "There isn't any PROFITS in a CURE" So I am happy about the new drugs and what they do but VERY concerned about where this is going.

Leonardo, Middletown, NJ, 2007-11-25 07:50:21
"They have the disease for life, and that's why the market is growing." Does the prospect of having lifelong customers, why would any drug company want to develop an actual cure? Scary.

comments 1 - 3 (of 3 total)    


[Go to top]


Get Answers
What to do if you've just been diagnosed
How to find a support system
Things you should know before starting treatment
How to handle side effects and other concerns
How to tell someone you have HIV/AIDS

Blogs by HIV+ Women
Regan Ann Michelle Annette

Read the blogs
Woman of the Month
Beth Benne: Nursing HIV Awareness
Beth Benne, RN, is HIV negative, but the virus has impacted her life. She currently supervises a biannual HIV/AIDS awareness week as the director of the student health center at Pierce College, a community commuter school in Woodland Hills, California. 


Woman of the Month is supported by exclusive advertising from Gilead.
Overheard in the Women's Forum
"I recently met a guy who is negative. I did tell him about my status and he decided to kiss me anyway (we didn't go further than that). But a day later, he called and said that he actually had a mouth ulcer that time when we kissed and he was very worried. Asked if he can get the virus from me that way. For that moment, I felt so insulted and yet I felt so bad. It was my first time having a contact with a "negative" guy."

from Positive Women


Join the forums

Smart + Strong Network
POZ Magazine
POZ Personals
POZ Mentor
POZ ASO Directory
AIDSmeds
Real Health Magazine
TuSalud Magazine
ComboCards
Rx Info Cards
Also visit POZ on...
Facebook

MySpace

YouTube

 
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertise/contact us | site map]
© 2008 Smart + Strong. All Rights Reserved. Terms of use and Your privacy